NIH-funded research R01 grant

Finding genes that shape core autism traits

Official title: 4/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder

Funded at University of Oxford · NIH-11303271 · Data updated 2026-11-12

This project looks for genes that increase the chance of autism and explains how those genes change core autism traits in autistic people and their families.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Oxford
NIH-funded
Lab location1 site (Oxford, United Kingdom)
Project startMarch 1, 2022
Project endDecember 31, 2026
Funding year2026
Award (this year)$267,339
NIH project number5R01MH129751-05
Project IDNIH-11303271 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are autistic people and their family members, or people with related developmental or neuropsychiatric conditions who can provide genetic samples or allow access to sequencing data.

Less likely to help

People looking for immediate changes in clinical care or whose autism has no identifiable genetic component may not see direct short-term benefits.

What this research studies

Researchers are analyzing DNA from tens of thousands of people — including autistic individuals, their family members, people with other developmental or psychiatric conditions, and people from population studies — to find rare genetic changes linked to autism. They focus on rare single-letter DNA changes, small insertions/deletions, copy number changes, inherited and X-linked variants, and specific missense mutations. The team builds on prior work that identified about 185 autism-associated genes and aims to double the number of known genes and learn which genes specifically affect core autism features. Much of the work combines existing sequencing data across international sites to increase the power to detect meaningful genetic signals.

Why it matters

Potential benefit: If successful, this work could make genetic testing more informative and point to biological targets that support better diagnosis, counseling, and future tailored treatments.

How similar studies have gone: Yes — earlier large-scale sequencing by the Autism Sequencing Consortium has already discovered many autism risk genes, demonstrating this approach can work.

Where this research is happening

  • University of Oxford
    Oxford, United Kingdom
    Active

Researchers

  • Principal investigator: Sanders, Stephan — University of Oxford
  • Study coordinator: Sanders, Stephan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.